| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 12.340 | 34.391 | 42.353 | 42.743 | 53.438 |
| Total Income - EUR | - | - | - | - | - | 12.450 | 36.114 | 65.232 | 45.155 | 53.442 |
| Total Expenses - EUR | - | - | - | - | - | 1.983 | 7.048 | 33.424 | 17.527 | 39.060 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 10.467 | 29.066 | 31.808 | 27.628 | 14.382 |
| Net Profit/Loss - EUR | - | - | - | - | - | 10.094 | 28.158 | 30.538 | 27.201 | 12.778 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Cardiosan Alpha S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 1.068 | 8.493 | 41.151 | 48.804 | 94.305 |
| Current Assets | - | - | - | - | - | 8.463 | 26.642 | 15.620 | 23.502 | 18.065 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 7.126 | 0 | 7.465 | 7.926 | 424 |
| Cash | - | - | - | - | - | 1.337 | 26.642 | 8.155 | 15.576 | 17.641 |
| Shareholders Funds | - | - | - | - | - | 10.176 | 33.691 | 55.048 | 71.095 | 75.872 |
| Social Capital | - | - | - | - | - | 83 | 81 | 81 | 81 | 80 |
| Debts | - | - | - | - | - | 1.606 | 1.444 | 4.257 | 3.738 | 39.011 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Cardiosan Alpha S.r.l.